May 17, 2018 / 2:33 PM / 7 days ago

BRIEF-FDA Says Making List Of Cos Blocking Access To Samples Of Branded Products

May 17 (Reuters) - FDA:

* FDA COMMISSIONER SCOTT GOTTLIEB SAYS MAKING PUBLIC LIST OF COS THAT HAVE POTENTIALLY BEEN BLOCKING ACCESS TO THE SAMPLES OF THEIR BRANDED PRODUCTS

* FDA’S GOTTLIEB - ALSO NOTIFYING FEDERAL TRADE COMMISSION ABOUT INQUIRIES RECEIVED FROM GENERIC DRUG DEVELOPERS

* FDA’S GOTTLIEB - FDA WILL DETERMINE WHETHER THE PRODUCTS HAVE IN PLACE RISK EVALUATION & MITIGATION STRATEGY PROGRAM WITH ETASU THAT MAY IMPACT DISTRIBUTION

* FDA’S GOTTLIEB SAYS IN MANY CASES, WE FIND THAT THERE’S NO SUCH REMS PROGRAM IN PLACE

* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE NOVARTIS PHARMA, ACTELION PHARMA, VALEANT, SMITHKLINE BEECHAM, GILEAD, CELGENE

* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE BIOGEN IDEC, INSYS THERAPEUTICS, LUNDBECK LLC, HYPERION THERAPEUTICS, VIVUS INC

* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE PFIZER PHARMACEUTICALS PRODUCTION, SWEDISH ORPHAN BIOVITRUM, MEDA PHARMA

* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE DANCO LABORATORIES, ROXANE LABORATORIES, CORCEPT THERAPEUTICS, AEGERION PHARMA

* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE PHARMACIA AND UPJOHN CO, QUESTCOR PHARMACEUTICALS, BOEHRINGER INGELHEIM, NPS PHARMA

* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE SHIRE ORPHAN THERAPIES, APOPHARMA, CEPHALON INC, JAZZ PHARMA, CUBIST PHARMA

* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE TEVA PHARMA USA, ALPHARMA PHARMA, ORPHAN EUROPE SARL, HERITAGE LIFE SCIENCES

* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE ASTRAZENECA LP, ACORDA THERAPEUTICS, MYLAN PHARMA, NOVARTIS PHARMA

* FDA’S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE BAYER HEALTHCARE PHARMA, ROCHE PALO ALTO, GALENA BIOPHARMA

* FDA'S GOTTLIEB - COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE RANBAXY INC/SUN PHARMACEUTICAL INDUSTRIES INC Source text : (bit.ly/2rRalSM) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below